Preliminary scientific tests suggest conolidine may well inhibit precise ion channels, cutting down neuronal excitability and restricting pain indicators. This system is especially applicable in neuropathic ache, where abnormal signaling leads to persistent irritation. Moreover, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to discomfort perception. ... https://patricko703hns4.wikinewspaper.com/user